Synelisa Parietal Cell Antibodies

FDA 510(k) K930422 · Elias U.S.A., Inc.

Substantially Equivalent

510(k) numberK930422

Submission

Device name
Synelisa Parietal Cell Antibodies
Applicant
Elias U.S.A., Inc.
Osceola, WI, US
Received
January 26, 1993
Decision date
August 3, 1993
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DBJ – Antiparietal Antibody, Indirect Immunofluorescent, Antigen, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5110
Specialty
Immunology

Other 510(k)s with product code DBJ

510(k)DeviceApplicantDecision
K790759Iif-Apca Test KitDBJ · Traditional Medica Corp.07/30/1979SE

More from Medica Corp.

510(k)DeviceDecision
K964385Elias ANA-HEP-2LJM · Traditional 03/06/1997SE
K963291Varelisa Ana (4) ProfileLJM · Traditional 09/30/1996SE
K953873Varelisa Helicobacter Pylori AntibodiesLYR · Traditional 08/30/1996SE
K953587Varelisa Mpo-AncaMOB · Traditional 01/26/1996SE
K953586Varelisa PR3-ANCAMOB · Traditional 01/26/1996SE
K951187Varelisa Cardiolipin Abs ScreenMID · Traditional 10/02/1995SE
K951207Varelisa Histone AntibodiesLJM · Traditional 04/17/1995SE
K951206Varelisa Parietal Cell AntibodiesMLE · Traditional 04/17/1995SE
K951205Varelisa Ana ProfileLJM · Traditional 04/17/1995SE
K951186Varelisa ANA-4 ScreenLJM · Traditional 04/17/1995SE

Questions and answers

When was Synelisa Parietal Cell Antibodies cleared by the FDA?

Synelisa Parietal Cell Antibodies (K930422) received a 510(k) decision of Substantially Equivalent on August 3, 1993, 189 days after the submission was received.

What is the product code of K930422?

The FDA product code is DBJ – Antiparietal Antibody, Indirect Immunofluorescent, Antigen, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5110.